Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm -9-MTH parent results

Feb 3 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.57                8.15             11.50     
                 (+5.1 pct)          (+3.1 pct)       (+7.1 pct)   
  Operating        221 mln             331 mln          130 mln    
                 (-33.1 pct)         (+4.9 pct)       (-35.9 pct)  
  Recurring        280 mln             397 mln          200 mln    
                 (-29.3 pct)         (-6.1 pct)       (-14.4 pct)  
  Net              168 mln             254 mln          110 mln    
                 (-33.8 pct)         (+4.7 pct)       (+32.0 pct)  
  EPS             4.85 yen            7.32 yen         3.17 yen    
  Ann Div                             3.00 yen         3.00 yen    
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen         3.00 yen    
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Wakamoto Pharmaceutical

See all news